Increased incidence of pneumococcal bloodstream infections

Related Experiment Video

Updated: Sep 20, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Marta Rodríguez-Créixems1, Juan Bertó, Patricia Muñoz

  • 1Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

The Pediatric Infectious Disease Journal
|July 31, 2003
PubMed

Insights

Pneumococcal bloodstream infections significantly increased in children between 1986 and 2000. The heptavalent vaccine covers most serogroups responsible for these infections.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Vaccinology

Background:

  • Pneumococcal bloodstream infections (PBSI) pose a significant threat to pediatric populations.
  • Surveillance data from 1986-2000 indicated a concerning rise in PBSI incidence.
  • Understanding trends in PBSI is crucial for public health interventions.

Purpose of the Study:

  • To analyze the incidence trends of pneumococcal bloodstream infections in pediatric patients.
  • To assess the potential impact of the heptavalent pneumococcal conjugate vaccine on PBSI rates.

Main Methods:

  • Retrospective analysis of PBSI cases in a defined population (approx. 650,000 inhabitants).
  • Calculation of incidence rates per 100,000 population, stratified by age groups.
  • Comparison of incidence rates between 1986 and 2000.

Main Results:

  • Overall PBSI incidence in pediatric patients rose from 3.6 to 14.8 episodes per 100,000.
  • Incidence in children under 24 months increased dramatically from 7.4 to 78.6 episodes per 100,000 per year.
  • The new heptavalent vaccine encompasses 75% of the identified serogroups.

Conclusions:

  • There was a substantial increase in pediatric pneumococcal bloodstream infections from 1986 to 2000.
  • The findings highlight the need for effective prevention strategies, such as vaccination.
  • The heptavalent vaccine's coverage of major serogroups offers a promising tool to combat PBSI.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...